Versican: Signaling to transcriptional control pathways

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 1, 2006, Pages 77-92

  Rahmani, Maziar ^a   Wong, Brian W ^a   Ang, Lisa ^a   Cheung, Caroline C ^a   Carthy, Jon M ^a   Walinski, Hubert ^a   McManus, Bruce M ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Promoter; Proteoglycan; Signaling pathway; Transcription factor; Versican

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GENISTEIN; GLYCOGEN SYNTHASE KINASE; HERMES ANTIGEN; L SELECTIN; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; PROTEOGLYCAN; TRANSCRIPTION FACTOR PAX3; VERSICAN;

ANGIOGENESIS; ATHEROSCLEROSIS; CANCER; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DNA METHYLATION; DRUG INHIBITION; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; HUMAN; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR DISEASE;

ANIMALS; HUMANS; LECTINS, C-TYPE; PROTEOCHONDROITIN SULFATES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VERSICANS;

EID: 33745737475     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-154     Document Type: Conference Paper

References (137)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. 1997. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16: 3797-3804. doi: 10.1093/emboj/16.13.3797. PMID: 9233789.
2. Archer, S.Y., and Hodin, R.A. 1999. Histone acetylation and cancer. Curr. Opin. Genet. Dev. 9: 171-174. doi: 10.1016/S0959-437X(99)80026-4. PMID: 10322142.
3. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J.R., and Yamada, Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23: 354-358. PMID: 10545953.
4. Asher, R.A., Morgenstern, D.A., Shearer, M.C., Adcock, K.H., Pesheva, P., and Fawcett, J.W. 2002. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J. Neurosci. 22: 2225-2236. PMID: 11896162.
5. Banerjee, A.G., Liu, J., Yuan, Y., Gopalakrishnan, V.K., Johansson, S.L., Dinda, A.K., et al. 2003. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. Mol. Cancer, 2: 34. doi: 10.1186/1476-4598-2-34. PMID: 14613585.
6. Banerjee, A.G., Bhattacharyya, I., and Vishwanatha, J.K. 2005. Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol. Cancer Ther. 4: 865-875. PMID: 15956244.
7. Bargonetti, J., and Manfredi, J.J. 2002. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14: 86-91. doi: 10.1097/00001622-200201000- 00015. PMID: 11790986.
8. Biggs, W.H., 3rd, Meisenhelder, J., Hunter, T., Cavenee, W.K., and Arden, K.C. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA, 96: 7421-7426. doi: 10.1073/pnas.96.13.7421. PMID: 10377430.
9. Botchkarev, V.A., and Kishimoto, J. 2003. Molecular control of epithelial-mesenchymal interactions during hair follicle cycling. J. Investig. Dermatol. Symp. Proc. 8: 46-55. doi: 10.1046/j. 1523-1747.2003.12171.x. PMID: 12894994.
10. Bouterfa, H., Darlapp, A.R., Klein, E., Pietsch, T., Roosen, K., and Tonn, J.C. 1999. Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J. Neurooncol. 44: 23-33. doi: 10.1023/A:1006331416283. PMID: 10582665.
11. Brown, L.F., Guidi, A.J., Schnitt, S.J., Van De Water, L., Iruela-Arispe, M.L., Yeo, T.K., Tognazzi, K., and Dvorak, H.F. 1999. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5: 1041-1056. PMID: 10353737.
12. Brunei, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96: 857-868. doi: 10.1016/S0092-8674(00) 80595-4. PMID: 10102273.
13. Chalepakis, G., Jones, F.S., Edelman, G.M., and Gruss, P. 1994. Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA, 91: 12745-12749. PMID: 7809114.
14. Chang, Y., Yanagishita, M., Hascall, V.C., and Wight, T.N. 1983. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J. Biol. Chem. 258: 5679-5688. PMID: 6406504.
15. Chen, C., Edelstein, L.C., and Gelinas, C. 2000. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20: 2687-2695. doi: 10.1128/MCB.20.8.2687-2695.2000. PMID: 10733571.
16. Chen, L., Wu, Y., Lee, V., Kiani, C., Adams, M.E., Yao, Y., and Yang, B.B. 2002. The folded modules of aggrecan G3 domain exert two separable functions in glycosaminoglycan modification and product secretion. J. Biol. Chem. 277: 2657-2665. doi: 10.1074/jbc.M101153200. PMID: 11714693.
17. Chu, Z.L., McKinsey, T.A., Liu, L., Gentry, J.J., Malim, M.H., and Ballard, D.W. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA, 94: 10057-10062. doi: 10.1073/pnas.94.19.10057. PMID: 9294162.
18. Cohen, P., and Frame, S. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2: 769-776. doi: 10.1038/35096075. PMID: 11584304.
19. Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., et al. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147: 1109-1122. doi: 10.1083/jcb.147.5. 1109. PMID: 10579729.
20. Cowin, P. 1994. Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc. Natl. Acad. Sci. USA, 91: 10759-10761. PMID: 7971957.
21. Cross, D.A., Alessi, D.R., Vandenheede, J.R., McDowell, H.E., Hundal, H.S., and Cohen, P. 1994. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303: 21-26. PMID: 7945242.
22. Cross, N.A., Chandrasekharan, S., Jokonya, N., Fowles, A., Hamdy, F.C., Buttle, D.J., and Eaton, C.L. 2005. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate, 63: 269-275. doi: 10.1002/pros.20182. PMID: 15599946.
23. Cunningham, J.M., Christensen, E.R., Tester, D.J., Kim, C.Y., Roche, P.C., Burgart, L.J., and Thibodeau, S.N. 1998. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58: 3455-3460. PMID: 9699680.
24. Daston, G., Lamar, E., Olivier, M., and Goulding, M. 1996. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development, 122: 1017-1027. PMID: 8631247.
25. Daya-Grosjean, L., and Couve-Privat, S. 2005. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett. 225: 181-192. PMID: 15978322.
26. Ding, V.W., Chen, R.H., and McCormick, F. 2000. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 275: 32475-32481. doi: 10.1074/jbc.M005342200. PMID: 10913153.
27. Doble, B.W., and Woodgett, J.R. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116: 1175-1186. doi: 10. 1242/jcs.00384. PMID: 12615961.
28. Domenzain, C., Docampo, M.J., Serra, M., Miquel, L., and Bassols, A. 2003. Differential expression of versican isoforms is a component of the human melanoma cell differentiation process. Biochim. Biophys. Acta, 1642: 107-114. PMID: 12972299.
29. Dours-Zimmermann, M.T., and Zimmermann, D.R. 1994. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269: 32992-32998. PMID: 7806529.
30. Downward, J. 2004. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15: 177-182. doi: 10.1016/j.semcdb.2004.01.002. PMID: 15209377.
31. Echelard, Y., Epstein, D.J., St-Jacques, B., Shen, L., Mohler, J., McMahon, J.A., and McMahon, A.P. 1993. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell, 75: 1417-1430. doi: 10.1016/0092-8674(93)90627-3. PMID: 7916661.
32. Edelman, G.M., and Jones, F.S. 1995. Developmental control of N-CAM expression by Hox and Pax gene products. Philos. Trans. R. Soc. Lond. B Biol. Sci. 349: 305-312. PMID: 8577842.
33. Evanko, S.P., and Vogel, K.G. 1993. Proteoglycan synthesis in fetal tendon is differentially regulated by cyclic compression in vitro. Arch. Biochem. Biophys. 307: 153-164. doi: 10.1006/abbi. 1993.1574. PMID: 7694546.
34. Fedtsova, N., Perris, R., and Turner, E.E. 2003. Sonic hedgehog regulates the position of the trigeminal ganglia. Dev. Biol. 261: 456-469. doi: 10.1016/S0012-1606(03)00316-6. PMID: 14499653.
35. Goodwin, A.M., and D'Amore, P.A. 2002. Wnt signaling in the vasculature. Angiogenesis, 5: 1-9. doi: 10.1023/A:1021563510866. PMID: 12549854.
36. Gorlin, R.J. 1995. Nevoid basal cell carcinoma syndrome. Dermatol. Clin. 13: 113-125. PMID: 7712637.
37. Goulding, M.D., Chalepakis, G., Deutsch, U., Erselius, J.R., and Gruss, P. 1991. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10: 1135-1147. PMID: 2022185.
38. Guevara, N.V., Kim, H.S., Antonova, E.I., and Chan, L. 1999. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat. Med. 5: 335-339. PMID: 10086392.
39. Harwood, A.J. 2001. Regulation of GSK-3: a cellular multiprocessor. Cell, 105: 821-824. doi: 10.1016/S0092-8674(01)00412-3. PMID: 11439177.
40. Haupt, S., Berger, M., Goldberg, Z., and Haupt, Y. 2003. Apoptosis -the p53 network. J. Cell Sci. 116: 4077-4085. doi: 10. 1242/jcs.00739. PMID: 12972501.
41. Henderson, D.J., Ybot-Gonzalez, P., and Copp, A.J. 1997. Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch). Mech. Dev. 69: 39-51. doi: 10.1016/S0925-4773(97)00151-2. PMID: 9486530.
42. Ihling, C., Haendeler, J., Menzel, G., Hess, R.D., Fraedrich, G., Schaefer, H.E., and Zeiher, A.M. 1998. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J. Pathol. 185: 303-312. doi: 10.1002/(SICI)1096- 9896(199807)185:3<303::AIDPATH106>3.0.CO;2-P. PMID: 9771485.
43. Iozzo, R.V., and Murdoch, A.D. 1996. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10: 598-614. PMID: 8621059.
44. Iozzo, R.V., Naso, M.F., Cannizzaro, L.A., Wasmuth, J.J., and McPherson, J.D. 1992. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics, 14: 845-851. doi: 10.1016/S0888- 7543(05) 80103-X. PMID: 1478664.
45. Iozzo, R.V., Cohen, I.R., Grassel, S., and Murdoch, A.D. 1994. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302: 625-639. PMID: 7945186.
46. Issa, J.P., Ahuja, N., Toyota, M., Bronner, M.P., and Brentnall, T.A. 2001. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61: 3573-3577. PMID: 11325821.
47. Ito, K., Shinomura, T., Zako, M., Ujita, M., and Kimata, K. 1995. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. Biol. Chem. 270: 958-965. PMID: 7822336.
48. Jacobson, S., and Pillus, L. 1999. Modifying chromatin and concepts of cancer. Curr. Opin. Genet. Dev. 9: 175-184. doi: 10. 1016/S0959-437X(99)80027-6. PMID: 10322138.
49. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J., and Wolffe, A.P. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19: 187-191. doi: 10.1038/561. PMID: 9620779.
50. Kiani, C., Lee, V., Cao, L., Chen, L., Wu, Y., Zhang, Y., Adams, M.E., and Yang, B.B. 2001. Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion. Biochem. J. 354: 199-207. doi: 10.1042/0264-6021:3540199. PMID: 11171095.
51. Kiani, C., Chen, L., Lee, V., Zheng, P.S., Wu, Y., Wen, J., et al. 2003. Identification of the motifs and amino acids in aggrecan G1 and G2 domains involved in product secretion. Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion. Biochemistry, 42: 7226-7237. doi: 10.1021/bi027241z. PMID: 12795619.
52. Kimata, K., Oike, Y., Tani, K., Shinomura, T., Yamagata, M., Uritani, M., and Suzuki, S. 1986. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J. Biol. Chem. 261: 13517-13525. PMID: 3759975.
53. Kinsella, M.G., Bressler, S.L., and Wight, T.N. 2004. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14: 203-234. doi: 10.1615/CritRevEukaryotGeneExpr.v14.i3.40. PMID: 15248816.
54. Kishimoto, J., Ehama, R., Wu, L., Jiang, S., Jiang, N., and Burgeson, R.E. 1999. Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development. Proc. Natl. Acad. Sci. USA, 96: 7336-7341. doi: 10. 1073/pnas.96.13.7336. PMID: 10377415.
55. Kishimoto, J., Burgeson, R.E., and Morgan, B.A. 2000. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev. 14: 1181-1185. PMID: 10817753.
56. Kitagawa, H., Tsutsumi, K., Tone, Y., and Sugahara, K. 1997. Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain. J. Biol. Chem. 272: 31377-31381. doi: 10.1074/jbc.272.50.31377. PMID: 9395468.
57. Koninger, J., Giese, T., di Mola, F.F., Wente, M.N., Esposito, I., Bachem, M.G., et al. 2004. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem. Biophys. Res. Commun. 322: 943-949. doi: 10.1016/j.bbrc.2004.08.008. PMID: 15336555.
58. Kops, G.J., de Ruiter, N.D., De Vries-Smits, A.M., Powell, D.R., Bos, J.L., and Burgering, B.M. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature, 398: 630-634. PMID: 10217147.
59. Korswagen, H.C., and Clevers, H.C. 1999. Activation and repression of wingless/Wnt target genes by the TCF/LEF-1 family of transcription factors. Cold Spring Harb. Symp. Quant. Biol. 64: 141-147. doi: 10.1101/sqb.1999.64.141. PMID: 11232279.
60. Krull, C.E. 2001. Segmental organization of neural crest migration. Mech. Dev. 105: 37-45. doi: 10.1016/S0925-4773(01)00395-1. PMID: 11429280.
61. Kusaba, H., Nakayama, M., Harada, T., Nomoto, M., Kohno, K., Kuwano, M., and Wada, M. 1999. Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells. Eur. J. Biochem. 262: 924-932. doi: 10.1046/j.1432-1327.1999.00469.X. PMID: 10411657.
62. Landolt, R.M., Vaughan, L., Winterhalter, K.H., and Zimmermann, D.R. 1995. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development, 121: 2303-2312. PMID: 7671797.
63. Maehama, T., and Dixon, I.E. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9: 125-128. doi: 10.1016/S0962-8924(99)01519-6. PMID: 10203785.
64. Makatsori, E., Lamari, F.N., Theocharis, A.D., Anagnostides, S., Hjerpe, A., Tsegenidis, T., and Karamanos, N.K. 2003. Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Res. 23: 3303-3309. PMID: 12926067.
65. Mann, R.K., and Beachy, P.A. 2004. Novel lipid modifications of secreted protein signals. Annu. Rev. Biochem. 73: 891-923. doi: 10.1146/annurev.biochem. 73.011303.073933. PMID: 15189162.
66. Maroto, M., Reshef, R., Munsterberg, A.E., Koester, S., Goulding, M., and Lassar, A.B. 1997. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell, 89: 139-148. doi: 10.1016/S0092-8674(00)80190-7. PMID: 9094722.
67. Mauri, P., Scarpa, A., Nascimbeni, A.C., Benazzi, L., Parmagnani, E., Mafficini, A., et al. 2005. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J. 19: 1125-1127. PMID: 15985535.
68. Mayanil, C.S., George, D., Freilich, L., Miljan, E.J., Mania-Farnell, B., McLone, D.G., and Bremer, E.G. 2001. Microarray analysis detects novel Pax3 downstream target genes. J. Biol. Chem. 276: 49299-49309. doi: 10.1074/jbc.M107933200. PMID: 11590174.
69. McMahon, A.P., Ingham, P.W., and Tabin, C.J. 2003. Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 53: 1-114. PMID: 12509125.
70. Meehan, R.R., Lewis, J.D., and Bird, A.P. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20: 5085-5092. PMID: 1408825.
71. Mercer, J., Figg, N., Stoneman, V., Braganza, D., and Bennett, M.R. 2005. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ. Res. 96: 667-674. doi: 10.1161/01.RES. 0000161069.15577.ca. PMID: 15746445.
72. Morgenstern, D.A., Asher, R.A., and Fawcett, J.W. 2002. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137: 313-332. PMID: 12440375.
73. Mullor, J.L., Sanchez, P., and Altaba, A.R. 2002. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 12: 562-569. doi: 10.1016/S0962-8924(02)02405-4. PMID: 12495844.
74. Murakami, T., and Ohtsuka, A. 2003. Perisynaptic barrier of proteoglycans in the mature brain and spinal cord. Arch. Histol. Cytol. 66: 195-207. doi: 10.1679/aohc.66.195. PMID: 14527161.
75. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393: 386-389. PMID: 9620804.
76. Nara, Y., Kato, Y., Torii, Y., Tsuji, Y., Nakagaki, S., Goto, S., et al. 1997. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican. Histochem. J. 29: 21-30. doi: 10.1023/A:1026460700592. PMID: 9088942.
77. Naso, M.F., Morgan, J.L., Buchberg, A.M., Siracusa, L.D., and Iozzo, R.V. 1995. Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13. Genomics, 29: 297-300. doi: 10.1006/geno.1995.1251. PMID: 8530092.
78. Naso, M.F., Zimmermann, D.R., and Iozzo, R.V. 1994a. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J. Biol. Chem. 269: 32999-33008. PMID: 7528742.
79. Naso, M.F., Zimmermann, D.R., and Iozzo, R.V. 1994b. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J. Biol. Chem. 269: 32999-33008. PMID: 7528742.
80. Nieto, M.A. 2001. The early steps of neural crest development. Mech. Dev. 105: 27-35. doi: 10.1016/S0925-4773(01)00394-X. PMID: 11429279.
81. Pathi, S., Pagan-Westphal, S., Baker, D.P., Garber, E.A., Rayhorn, P., Bumcrot, D., et al. 2001. Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech. Dev. 106: 107-117. doi: 10.1016/S0925- 4773(01)00427-0. PMID: 11472839.
82. Paulus, W., Baur, I., Dours-Zimmermann, M.T., and Zimmermann, D.R. 1996. Differential expression of versican isoforms in brain tumors. J. Neuropathol. Exp. Neurol. 55: 528-533. PMID: 8627343.
83. Perris, R., and Perissinotto, D. 2000. Role of the extracellular matrix during neural crest cell migration. Mech. Dev. 95: 3-21. doi: 10.1016/S0925-4773(00)00365-8. PMID: 10906446.
84. Pirinen, R., Leinonen, T., Bohm, J., Johansson, R., Ropponen, K., Kumpulainen, E., and Kosma, V.M. 2005. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Hum. Pathol. 36: 44-50. doi: 10.1016/j. humpath.2004.10.010. PMID: 15712181.
85. Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14: 1837-1851. PMID: 10921899.
86. Porter, J.A., von Kessler, D.P., Ekker, S.C., Young, K.E., Lee, J.J., Moses, K., and Beachy, P.A. 1995. The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature, 374: 363-366. doi: 10.1038/374363a0. PMID: 7885476.
87. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878-4884. PMID: 8532532.
88. Rahmani, M., McDonald, P.C., Wong, B.W., and McManus, B.M. 2004. Transplant vascular disease: role of lipids and proteoglycans. Can. J. Cardiol. 20: 58B-65B. PMID: 15309207.
89. Rahmani, M., Read, J.T., Carthy, J.M., McDonald, P.C., Wong, B.W., Esfandiarei, M., et al. 2005. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. J. Biol. Chem. 280: 13019-13028. PMID: 15668231.
90. Rennie, P.S., and Nelson, C.C. 1998. Epigenetic mechanisms for progression of prostate cancer. Cancer Metastasis Rev. 17: 401-409. doi: 10.1023/A:1006121219097. PMID: 10453284.
91. Ricciardelli, C., Mayne, K., Sykes, P.J., Raymond, W.A., McCaul, K., Marshall, V.R., and Horsfall, D.J. 1998. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin. Cancer Res. 4: 963-971. PMID: 9563891.
92. Ricciardelli, C., Brooks, J.H., Suwiwat, S., Sakko, A.J., Mayne, K., Raymond, W.A., et al. 2002. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin. Cancer Res. 8: 1054-1060. PMID: 11948113.
93. Riccio, A., Ahn, S., Davenport, C.M., Blendy, J.A., and Ginty, D.D. 1999. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science, 286: 2358-2361. doi: 10.1126/science.286.5448. 2358. PMID: 10600750.
94. Roessler, E., Belloni, E., Gaudenz, K., Jay, P., Berta, P., Scherer, S.W., Tsui, L.C., and Muenke, M. 1996. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat. Genet. 14: 357-360. doi: 10.1038/ng1196-357. PMID: 8896572.
95. Ruiz i Altaba, A., Sanchez, P., and Dahmane, N. 2002. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer, 2: 361-372. doi: 10.1038/nrc796. PMID: 12044012.
96. Ruoslahti, E. 1996. Brain extracellular matrix. Glycobiology, 6: 489-492. PMID: 8877368.
97. Sakko, A.J., Ricciardelli, C., Mayne, K., Tilley, W.D., Lebaron, R.G., and Horsfall, D.J. 2001. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res. 61: 926-930. PMID: 11221884.
98. Sakko, A.J., Ricciardelli, C., Mayne, K., Suwiwat, S., LeBaron, R.G., Marshall, V.R., Tilley, W.D., and Horsfall, D.J. 2003. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res. 63: 4786-4791. PMID: 12941795.
99. Schmalfeldt, M., Dours-Zimmermann, M.T., Winterhalter, K.H., and Zimmermann, D.R. 1998. Versican V2 is a major extracellular matrix component of the mature bovine brain. J. Biol. Chem. 273: 15758-15764. doi: 10.1074/jbc.273.25.15758. PMID: 9624174.
100. Schonherr, E., Jarvelainen, H.T., Sandell, L.J., and Wight, T.N. 1991a. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266: 17640-17647. PMID: 1894644.
101. Schonherr, E., Jarvelainen, H.T., Sandell, L.J., and Wight, T.N. 1991b. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266: 17640-17647. PMID: 1894644.
102. Schonherr, E., Kinsella, M.G., and Wight, T.N. 1997. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch. Biochem. Biophys. 339: 353-361. doi: 10.1006/abbi.1996.9854. PMID: 9056268.
103. Shimizu-Hirota, R., Sasamura, H., Mifune, M., Nakaya, H., Kuroda, M., Hayashi, M., and Saruta, T. 2001. Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors. J. Am. Soc. Nephrol. 12: 2609-2615. PMID: 11729229.
104. Shinomura, T., Nishida, Y., Ito, K., and Kimata, K. 1993. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J. Biol. Chem. 268: 14461-14469. PMID: 8314802.
105. Shinomura, T., Zako, M., Ito, K., Ujita, M., and Kimata, K. 1995. The gene structure and organization of mouse PG-M, a large chondroitin sulfate proteoglycan. Genomic background for the generation of multiple PG-M transcripts. J. Biol. Chem. 270: 10328-10333. PMID: 7730339.
106. Skandalis, S.S., Theocharis, A.D., Theocharis, D.A., Papadas, T., Vynios, D.H., and Papageorgakopoulou, N. 2004. Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma. Biochim. Biophys. Acta, 1689: 152-161. PMID: 15196596.
107. Soma, T., Tajima, M., and Kishimoto, J. 2005. Hair cycle-specific expression of versican in human hair follicles. J. Dermatol. Sci. 39: 147-154. doi: 10.1016/j.jdermsci.2005.03.010. PMID: 15871917.
108. Stigson, M., and Kjellen, L. 1996. Molecular cloning of a PG-M/versican-like proteoglycan of the axolotl embryo. In Large chondroitin sulfate proteoglycans in the axolotl embryo (Ph.D. thesis). Edited by M. Stigson. Uppsala University, Uppsala.
109. Suwiwat, S., Ricciardelli, C., Tammi, R., Tammi, M., Auvinen, P., Kosma, V.M., et al. 2004. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin. Cancer Res. 10: 2491-2498. PMID: 15073129.
110. Taipale, J., and Beachy, P.A. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature, 411: 349-354. doi: 10.1038/35077219. PMID: 11357142.
111. Tajbakhsh, S., Rocancourt, D., Cossu, G., and Buckingham, M. 1997. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell, 89: 127-138. doi: 10.1016/S0092-8674(00)80189- 0. PMID: 9094721.
112. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J., and Greenberg, M.E. 1998. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron, 20: 709-726. doi: 10.1016/S0896-6273(00)81010-7. PMID: 9581763.
113. Touab, M., Villena, J., Barranco, C., Arumi-Uria, M., and Bassols, A. 2002. Versican is differentially expressed in human melanoma and may play a role in tumor development. Am. J. Pathol. 160: 549-557. PMID: 11839575.
114. Touab, M., Arumi-Uria, M., Barranco, C., and Bassols, A. 2003. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi. Am. J. Clin. Pathol. 119: 587-593. PMID: 12710131.
115. Toyota, M., Ho, C., Ahuja, N., Jair, K.W., Li, Q., Ohe-Toyota, M., Baylin, S.B., and Issa, J.P. 1999. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59: 2307-2312. PMID: 10344734.
116. Voutilainen, K., Anttila, M., Sillanpaa, S., Tammi, R., Tammi, M., Saarikoski, S., and Kosma, V.M. 2003. Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int. J. Cancer, 107: 359-364. doi: 10.1002/ijc. 11423. PMID: 14506734.
117. Wetmore, C. 2003. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr. Opin. Genet. Dev. 13: 34-42. doi: 10.1016/S0959-437X(03)00002-9. PMID: 12573433.
118. Wight, T.N. 2002. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14: 617-623. doi: 10.1016/S0955- 0674(02)00375-7. PMID: 12231358.
119. Wight, T.N., and Merrilees, M.J. 2004. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94: 1158-1167. doi: 10.1161/01.RES.0000126921.29919.51. PMID: 15142969.
120. Willert, J., Epping, M., Pollack, J.R., Brown, P.O., and Nusse, R. 2002. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol. 2: 8. doi: 10.1186/1471-213X-2-8. PMID: 12095419.
121. Wolffe, A.P. 1998. Packaging principle: how DNA methylation and histone acetylation control the transcriptional activity of chromatin. J. Exp. Zool. 282: 239-244. doi: 10.1002/(SICI) 1097-010X(199809/10)282:1/2<239::AID- JEZ25>3.0.CO;2-N. PMID: 9723180.
122. Woodgett, J.R. 2005. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17: 150-157. doi: 10. 1016/j.ceb.2005.02.010. PMID: 15780591.
123. Wu, Y., Wu, J., Lee, D.Y., Yee, A., Cao, L., Zhang, Y., Kiani, C., and Yang, B.B. 2005a. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol. 24: 3-13. PMID: 15748997.
124. Wu, Y.J., Lapierre, D., Wu, J., Yee, A.J., and Yang, B.B. 2005b. The interaction of versican with its binding partners. Cell Res. 15: 483-494. PMID: 16045811.
125. Xie, J., Aszterbaum, M., Zhang, X., Bonifas, J.M., Zachary, C., Epstein, E., and McCormick, F. 2001. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. USA, 98: 9255-9259. doi: 10.1073/pnas.151173398. PMID: 11481486.
126. Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N., and Tohyama, M. 2001. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276: 5256-5264. doi: 10.1074/jbc.M008552200. PMID: 11054421.
127. Yang, B.L., Cao, L., Kiani, C., Lee, V., Zhang, Y., Adams, M.E., and Yang, B.B. 2000. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. J. Biol. Chem. 275: 21255-21261. doi: 10.1074/jbc.M001443200. PMID: 10801813.
128. Yao, L.Y., Moody, C., Schonherr, E., Wight, T.N., and Sandell, L.J. 1994. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 14: 213-225. doi: 10.1016/0945-053X(94)90185-6. PMID: 7921538.
129. Yeivin, A., and Razin, A. 1993. Gene methylation patterns and expression. In DNA methylation: molecular biology and biological significance. Edited by J.P. Jost and H.P. Saluz. Birkhauser, Boston. pp. 523-568.
130. Yoon, J.H., and Halper, J. 2005. Tendon proteoglycans: biochemistry and function. J. Musculoskelet. Neuronal Interact. 5: 22-34. PMID: 15788868.
131. Yoon, H., Liyanarachchi, S., Wright, P.A., Davuluri, R., Lockman, J.C., de la Chapelle, A., and Pellegata, N.S. 2002. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc. Natl. Acad. Sci. USA, 99: 15632-15637. doi: 10.1073/pnas.242597299. PMID: 12438652.
132. Zako, M., Shinomura, T., Ujita, M., Ito, K., and Kimata, K. 1995. Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J. Biol. Chem. 270: 3914-3918. PMID: 7876137.
133. Zako, M., Shinomura, T., and Kimata, K. 1997. Alternative splicing of the unique "PLUS" domain of chicken PG-M/versican is developmentally regulated. J. Biol. Chem. 272: 9325-9331. PMID: 9083069.
134. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W.H., et al. 2000. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14: 981-993. PMID: 10783169.
135. Zheng, P.S., Wen, J., Ang, L.C., Sheng, W., Viloria-Petit, A., Wang, Y., et al. 2004. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J. 18: 754-756. PMID: 14766798.
136. Zimmermann, D.R., and Ruoslahti, E. 1989. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8: 2975-2981. PMID: 2583089.
137. Zong, W.X., Edelstein, L.C., Chen, C., Bash, J., and Gelinas, C. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13: 382-387. PMID: 10049353.